The Cell and Molecular Biology of Carcinogenesis Laboratory is researching possible new therapeutic targets for intervention and treatment of pancreatic ductal adenocarcinoma.
The lab is investigating the role of atypical protein kinase C in the development and maintenance of pancreatic ductal adenocarcinoma. In addition, the lab is characterizing atypical protein kinase C as a potential therapeutic target for the treatment of pancreatic cancer.
The Cell and Molecular Biology of Carcinogenesis Laboratory is also developing new preclinical models for a more individualized approach to the development and screening of experimental therapeutics. The goal of these studies is to evaluate chemotherapy sensitivity and guide selection of chemotherapy for pancreatic cancer patients.